Nurmemmedov Lab
Laboratory of Preclinical Pharmacology of Novel Therapeutics
Principal Investigator: Elmar Nurmemmedov, PhD, MBA
Nurmemmedov Lab Home
Dr. Nurmemmedov has dedicated much of his scientific career to drug discovery in the field of ‘challenging’ drug targets, particularly transcription factors. At Scintillon Institute, Elmar’s research is focused on preclinical pharmacology of novel therapeutics…
